Clinical Trial Update: Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B Carriers [Phase 3]

View source ↗

Summary

This Phase 3 trial investigates prophylactic or preemptive entecavir in patients with inactive hepatitis B and gastrointestinal cancers. The aim is to prevent H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancers

Drugs mentioned

• Baraclude (entecavir)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Gastrointestinal Cancers | Phase 3 | Status: RECRUITING